Locate Montgomery buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Richard Alan Stehl, MD
P O Box 242522
Montgomery, AL 36124
Main Tel: 334-558-0908
|
|
Dr. Scott Alexander Bell, M.D.
138 Adams Ave. Suite 3
Montgomery, AL 36104
Main Tel: (334) 328-5574
|
|
Dr. Joseph Patrick Lucas, M.D.
4371 Narrow Lane Road
Montgomery, AL 36116
Main Tel: (334) 323-3307
|
|
Dr. Clemmie Lee Palmer, III, M.D.
3090 Woodley Road
Montgomery, AL 36116
Main Tel: (334) 280-3230
|
|
Dr. Gilberto Sanchez, M.D.
4143 Atlanta Highway
Montgomery, AL 36109
Main Tel: (334) 271-4503
|
|
DLivro L. Beauchamp, M.D.
4705 Woodmere Boulevard
Montgomery, AL 36106
Main Tel: (334) 558-0262
|
|
Dr. Gregory Philip Jones, D.O.
470 Taylor Road
Suite 300
Montgomery, AL 36117
Main Tel: (334) 281-1191
|
|
Dr. Shankar B. Yalamanchili, M.D.
233 Winton M Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
|
Dr. Anil Pal Saini,
233 Winton M. Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
|
Dr. Ramakanth K. Vemuluri,
7085 Sydney Curve
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
Buprenorphine Shown Safe and Effective in Reducing Opioid Use
A scholarly article published in The American Journal of Psychiatry found that buprenorphine was “noninferior” in elimiating opioid misuse as compared with methadone dosing. Noninferior is another way of saying reasonably similar in effectiveness. The study was based on 272 patients meeting diagnostic criteria for Opioid Use Disorder, and was conducted over a 24 week Read More
Opioid Use Disorder and Medication Assistance
Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy. Buprenorphine based medications enjoy a proven track record of success in helping patients achieve long lasting stablization and elimination of Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
A scholarly article published in 
Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy.